CASTLE BIOSCIENCES INC (CSTL) — insider trading
Health Care · NASDAQ
CASTLE BIOSCIENCES INC (CSTL) has 39 reported SEC Form 4 insider transactions in our data, including 24 open-market sales among the most recent 39 (latest 2026-07-01).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-01 | Oelschlager Kristen M | Officer (Chief Operating Officer) | Open-market sale | 400 | $24.78 | $9.9K | Form 4 |
| 2026-07-01 | Oelschlager Kristen M | Officer (Chief Operating Officer) | Open-market sale | 8,186 | $24.40 | $199.7K | Form 4 |
| 2026-07-01 | MAETZOLD DEREK J | Director, Officer (Pres. & Chief Exec. Officer) | Option exercise / conversion (derivative) | 6,214 | $0.00 | $0 | Form 4 |
| 2026-07-01 | MAETZOLD DEREK J | Director, Officer (Pres. & Chief Exec. Officer) | Open-market sale | 278 | $24.29 | $6.8K | Form 4 |
| 2026-07-01 | MAETZOLD DEREK J | Director, Officer (Pres. & Chief Exec. Officer) | Open-market sale | 278 | $24.29 | $6.8K | Form 4 |
| 2026-07-01 | MAETZOLD DEREK J | Director, Officer (Pres. & Chief Exec. Officer) | Open-market sale | 278 | $24.29 | $6.8K | Form 4 |
| 2026-07-01 | MAETZOLD DEREK J | Director, Officer (Pres. & Chief Exec. Officer) | Open-market sale | 278 | $24.29 | $6.8K | Form 4 |
| 2026-07-01 | MAETZOLD DEREK J | Director, Officer (Pres. & Chief Exec. Officer) | Open-market sale | 1,153 | $24.29 | $28.0K | Form 4 |
| 2026-07-01 | MAETZOLD DEREK J | Director, Officer (Pres. & Chief Exec. Officer) | Open-market sale | 1,357 | $24.29 | $33.0K | Form 4 |
| 2026-07-01 | MAETZOLD DEREK J | Director, Officer (Pres. & Chief Exec. Officer) | Open-market sale | 6,214 | $24.29 | $150.9K | Form 4 |
| 2026-07-01 | MAETZOLD DEREK J | Director, Officer (Pres. & Chief Exec. Officer) | Option exercise / conversion | 6,214 | $2.39 | $14.9K | Form 4 |
| 2026-06-16 | Oelschlager Kristen M | Officer (Chief Operating Officer) | Open-market sale | 8,587 | $20.71 | $177.8K | Form 4 |
| 2026-06-15 | MAETZOLD DEREK J | Director, Officer (Pres. & Chief Exec. Officer) | Option exercise / conversion (derivative) | 550 | $0.00 | $0 | Form 4 |
| 2026-06-15 | MAETZOLD DEREK J | Director, Officer (Pres. & Chief Exec. Officer) | Open-market sale | 278 | $20.66 | $5.7K | Form 4 |
| 2026-06-15 | MAETZOLD DEREK J | Director, Officer (Pres. & Chief Exec. Officer) | Open-market sale | 278 | $20.66 | $5.7K | Form 4 |
| 2026-06-15 | MAETZOLD DEREK J | Director, Officer (Pres. & Chief Exec. Officer) | Open-market sale | 278 | $20.66 | $5.7K | Form 4 |
| 2026-06-15 | MAETZOLD DEREK J | Director, Officer (Pres. & Chief Exec. Officer) | Open-market sale | 278 | $20.66 | $5.7K | Form 4 |
| 2026-06-15 | MAETZOLD DEREK J | Director, Officer (Pres. & Chief Exec. Officer) | Open-market sale | 1,153 | $20.66 | $23.8K | Form 4 |
| 2026-06-15 | MAETZOLD DEREK J | Director, Officer (Pres. & Chief Exec. Officer) | Open-market sale | 1,357 | $20.66 | $28.0K | Form 4 |
| 2026-06-15 | MAETZOLD DEREK J | Director, Officer (Pres. & Chief Exec. Officer) | Open-market sale | 550 | $20.66 | $11.4K | Form 4 |
| 2026-06-15 | MAETZOLD DEREK J | Director, Officer (Pres. & Chief Exec. Officer) | Option exercise / conversion | 550 | $2.39 | $1.3K | Form 4 |
| 2026-06-01 | MAETZOLD DEREK J | Director, Officer (Pres. & Chief Exec. Officer) | Option exercise / conversion (derivative) | 6,010 | $0.00 | $0 | Form 4 |
| 2026-06-01 | MAETZOLD DEREK J | Director, Officer (Pres. & Chief Exec. Officer) | Option exercise / conversion (derivative) | 204 | $0.00 | $0 | Form 4 |
| 2026-06-01 | MAETZOLD DEREK J | Director, Officer (Pres. & Chief Exec. Officer) | Open-market sale | 278 | $20.86 | $5.8K | Form 4 |
| 2026-06-01 | MAETZOLD DEREK J | Director, Officer (Pres. & Chief Exec. Officer) | Open-market sale | 278 | $20.86 | $5.8K | Form 4 |
| 2026-06-01 | MAETZOLD DEREK J | Director, Officer (Pres. & Chief Exec. Officer) | Open-market sale | 278 | $20.86 | $5.8K | Form 4 |
| 2026-06-01 | MAETZOLD DEREK J | Director, Officer (Pres. & Chief Exec. Officer) | Open-market sale | 278 | $20.86 | $5.8K | Form 4 |
| 2026-06-01 | MAETZOLD DEREK J | Director, Officer (Pres. & Chief Exec. Officer) | Open-market sale | 1,153 | $20.86 | $24.0K | Form 4 |
| 2026-06-01 | MAETZOLD DEREK J | Director, Officer (Pres. & Chief Exec. Officer) | Open-market sale | 1,357 | $20.86 | $28.3K | Form 4 |
| 2026-06-01 | MAETZOLD DEREK J | Director, Officer (Pres. & Chief Exec. Officer) | Open-market sale | 6,214 | $20.86 | $129.6K | Form 4 |
| 2026-06-01 | MAETZOLD DEREK J | Director, Officer (Pres. & Chief Exec. Officer) | Option exercise / conversion | 6,010 | $2.39 | $14.4K | Form 4 |
| 2026-06-01 | MAETZOLD DEREK J | Director, Officer (Pres. & Chief Exec. Officer) | Option exercise / conversion | 204 | $2.39 | $488 | Form 4 |
| 2026-05-28 | Cole G Bradley | Director | Grant / award / vesting (derivative) | 11,766 | $0.00 | $0 | Form 4 |
| 2026-05-28 | BRADBURY DANIEL | Director | Grant / award / vesting (derivative) | 11,766 | $0.00 | $0 | Form 4 |
| 2026-05-28 | Caple Kim | Director | Grant / award / vesting (derivative) | 11,766 | $0.00 | $0 | Form 4 |
| 2026-05-28 | Cotton Rodney | Director | Grant / award / vesting (derivative) | 11,766 | $0.00 | $0 | Form 4 |
| 2026-05-28 | Harrison Miles | Director | Grant / award / vesting (derivative) | 11,766 | $0.00 | $0 | Form 4 |
| 2026-05-28 | Goldberg Ellen | Director | Grant / award / vesting (derivative) | 11,766 | $0.00 | $0 | Form 4 |
| 2026-05-28 | Olson Tiffany | Director | Grant / award / vesting (derivative) | 11,766 | $0.00 | $0 | Form 4 |
Ask the chat about CSTL's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: CASTLE BIOSCIENCES INC (CSTL).
Last updated 2026-07-01 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.